BG
OGN icon

Bahl & Gaynor’s Organon & Co OGN Stock Holding History

Bahl & Gaynor’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,907
Closed -$210K – 343
2021
Q4 		$210K Sell
6,907
-33,627
-83% -$1.1M ﹤0.01% 329
2021
Q3 		$1.33M Sell
40,534
-72,440
-64% -$2.32M 0.01% 246
2021
Q2 		$3.42M Buy
+112,974
New +$3.72M 0.02% 194

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bahl & Gaynor's OGN Position: Q1 2022 in Review

Bahl & Gaynor sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 6,907 shares — an estimated $210K sold.

Bahl & Gaynor first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $3.42M in Q2 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Bahl & Gaynor reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • Bahl & Gaynor sold 6,907 Organon & Co shares in Q1 2022, an estimated $210K.
  • Bahl & Gaynor first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Bahl & Gaynor's Organon & Co position peaked at $3.42M in Q2 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Bahl & Gaynor's 13F filing for Q1 2022, filed 12 May 2022.